6-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-N-methyl-N-(pyrazin-2-ylmethyl)-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide

C20H23N5O2S — CID 118794357

IUPAC6-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-N-methyl-N-(pyrazin-2-ylmethyl)-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide
SMILESCc1noc(C)c1CN1CCc2c(C(=O)N(C)Cc3cnccn3)csc2C1
InChIInChI=1S/C20H23N5O2S/c1-13-17(14(2)27-23-13)10-25-7-4-16-18(12-28-19(16)11-25)20(26)24(3)9-15-8-21-5-6-22-15/h5-6,8,12H,4,7,9-11H2,1-3H3
InChIKeyGISIEVRBZADCMN-UHFFFAOYSA-N
MW397.50 g/mol
LogP2.97
Rot. Bonds5

About 6-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-N-methyl-N-(pyrazin-2-ylmethyl)-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide

6-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-N-methyl-N-(pyrazin-2-ylmethyl)-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide (PubChem CID 118794357) has the molecular formula C20H23N5O2S and a molecular weight of 397.50 g/mol. Its IUPAC name is 6-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-N-methyl-N-(pyrazin-2-ylmethyl)-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide.

Molecular Properties

Compound Name6-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-N-methyl-N-(pyrazin-2-ylmethyl)-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide
PubChem CID118794357
Molecular FormulaC20H23N5O2S
Molecular Weight397.50 g/mol
Exact Mass397.16
IUPAC Name6-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-N-methyl-N-(pyrazin-2-ylmethyl)-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide
SMILESCc1noc(C)c1CN1CCc2c(C(=O)N(C)Cc3cnccn3)csc2C1
InChIInChI=1S/C20H23N5O2S/c1-13-17(14(2)27-23-13)10-25-7-4-16-18(12-28-19(16)11-25)20(26)24(3)9-15-8-21-5-6-22-15/h5-6,8,12H,4,7,9-11H2,1-3H3
InChIKeyGISIEVRBZADCMN-UHFFFAOYSA-N
XLogP2.97
TPSA75.36 Ų
H-Bond Donors
H-Bond Acceptors7
Rotatable Bonds5
Heavy Atoms28
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500397.50
LogP ≤ 52.97
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 107

Analyze 6-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-N-methyl-N-(pyrazin-2-ylmethyl)-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-N-methyl-N-(pyrazin-2-ylmethyl)-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide?
The IUPAC name of 6-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-N-methyl-N-(pyrazin-2-ylmethyl)-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide (CID 118794357) is 6-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-N-methyl-N-(pyrazin-2-ylmethyl)-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide.
What is the SMILES notation for 6-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-N-methyl-N-(pyrazin-2-ylmethyl)-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide?
The canonical SMILES for 6-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-N-methyl-N-(pyrazin-2-ylmethyl)-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide is Cc1noc(C)c1CN1CCc2c(C(=O)N(C)Cc3cnccn3)csc2C1.
What is the InChIKey of 6-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-N-methyl-N-(pyrazin-2-ylmethyl)-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide?
The InChIKey is GISIEVRBZADCMN-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H23N5O2S/c1-13-17(14(2)27-23-13)10-25-7-4-16-18(12-28-19(16)11-25)20(26)24(3)9-15-8-21-5-6-22-15/h5-6,8,12H,4,7,9-11H2,1-3H3.
What are the key properties of 6-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-N-methyl-N-(pyrazin-2-ylmethyl)-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide?
6-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-N-methyl-N-(pyrazin-2-ylmethyl)-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide has a molecular weight of 397.50 g/mol, XLogP of 2.97, 5 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 6-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-N-methyl-N-(pyrazin-2-ylmethyl)-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide is sourced from PubChem (CID 118794357), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).